C07D 213/87
In position 3
Official title: in position 3
C07D213/87 (In position 3) appears on 82 US grants and 70 published applications in this corpus.
Search patents in C07D- Granted patents
- 82
- Published applications
- 70
- Assignees
- 51
- Inventors
- 210
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 2 | 0 |
| 1977 | 0 | 0 |
| 1978 | 2 | 0 |
| 1979 | 1 | 0 |
| 1980 | 1 | 0 |
| 1981 | 1 | 0 |
| 1982 | 0 | 0 |
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 2 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 2 | 0 |
| 1995 | 1 | 0 |
| 1996 | 2 | 0 |
| 1997 | 2 | 0 |
| 1998 | 0 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 3 | 1 |
| 2002 | 1 | 4 |
| 2003 | 4 | 4 |
| 2004 | 3 | 3 |
| 2005 | 1 | 4 |
| 2006 | 2 | 1 |
| 2007 | 4 | 2 |
| 2008 | 2 | 7 |
| 2009 | 1 | 1 |
| 2010 | 1 | 2 |
| 2011 | 0 | 1 |
| 2012 | 0 | 3 |
| 2013 | 3 | 4 |
| 2014 | 6 | 3 |
| 2015 | 4 | 5 |
| 2016 | 4 | 1 |
| 2017 | 4 | 3 |
| 2018 | 1 | 5 |
| 2019 | 2 | 2 |
| 2020 | 4 | 1 |
| 2021 | 0 | 3 |
| 2022 | 3 | 3 |
| 2023 | 1 | 2 |
| 2024 | 1 | 3 |
| 2025 | 4 | 1 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Perk inhibiting compounds18 Nov 2025US 12,473,296 B2HiberCell, Inc.
- Pyridinyl morpholine compound, preparation method therefor, and application thereof9 Sep 2025US 12,410,136 B2Shanghai Institute of Pharmaceutical Industry
- Fatty acid amide hydrolase modulators, compositions comprising the same and uses thereof9 Sep 2025US 12,410,137 B2Apogee Pharmaceuticals, Inc.
- Theramutein modultors18 Feb 2025US 12,226,420 B2HMI Medical Innovations, LLC
- Nav 1.7 and/or nav 1.8 blocking hydrazides, processes for the preparation thereof, compositions, uses, methods of treatment using same and kits6 Aug 2026US 2026/0226020 A1Eurofarma Laboratorios SA
- Fatty acid amide hydrolase modulators, compositions comprising the same and uses thereof24 Apr 2025US 2025/0129027 A1Apogee Pharmaceuticals, Inc.
- Sos1 inhibitor and use thereof5 Dec 2024US 2024/0400518 A1
- N-acylhydrazone compounds capable of inhibiting nav 1.7 and/or nav 1.8, processes for the preparation thereof, compositions, uses, methods for treatment using same and kits10 Oct 2024US 2024/0335420 A1Eurofarma Laboratorios SA
- Theramutein modultors6 Jun 2024US 2024/0180916 A1HMI Medical Innovations, LLC
Most cited
By later US patents
- Insecticidal N'-substituted-N,N'-disubstitutedhydrazines107US 6,013,836 ARohm and Haas Company · 2000
- Insecticidal N'-substituted-N,N'-diacylhydrazines72US 5,530,028 ARohm and Haas Company · 1996
- Anthelmintic N'-substituted-N,N'-disubstitutedhydrazines56US 5,424,333 ARohm and Haas Company · 1995
- Bioavailable diacylhydrazine ligands for modulating the expression of exogenous genes via an ecdysone receptor complex45US 7,456,315 B2Intrexon Corporation · 2008
- Retinoic acid derivatives33US 4,190,594 AJohnson & Johnson · 1980